Literature DB >> 7788006

Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy.

M Yamazaki1, S Ito, A Usami, N Tani, O Hanyu, O Nakagawa, H Nakamura, A Shibata.   

Abstract

The level of ceruloplasmin, which is a more negatively charged protein than albumin, was measured by an immunoradiometric assay in timed overnight urine and serum samples from patients with non-insulin-dependent diabetes mellitus and healthy controls. None of the plasma proteins examined showed any cross-reactivity in this assay. A linear correlation was seen between the ceruloplasmin level and the serial dilution of the sample. Western blot analysis using concentrated urine samples showed that the molecular weight of ceruloplasmin in the urine sample was the same as that of ceruloplasmin in the serum and standard samples. These findings indicated that the substance detected by this assay was truly ceruloplasmin. The urinary ceruloplasmin excretion rate (CER) and clearance of ceruloplasmin increased in parallel with the progression of albuminuria. The highest CER was found in macroalbuminuric patients, followed by micro- and normoalbuminuric patients and the healthy control subjects, the differences between the groups being significant. In view of the fact that the isoelectric point of ceruloplasmin (4.4) is more acidic than that of albumin, the present findings suggested that an enhanced CER was due either to the alteration of charge selectivity in the glomerular basement membrane with unaltered tubular function or to a defect of the non-discriminatory pores (shunt pathway) with unaltered tubular function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7788006     DOI: 10.1530/eje.0.1320681

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  6 in total

Review 1.  Biomarkers in diabetic nephropathy: Present and future.

Authors:  Gemma Currie; Gerard McKay; Christian Delles
Journal:  World J Diabetes       Date:  2014-12-15

2.  Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.

Authors:  Kinnari Mistry; Kiran Kalia
Journal:  Indian J Clin Biochem       Date:  2009-07-09

3.  Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.

Authors:  Santosh L Saraf; Justin R Sysol; Alexandru Susma; Suman Setty; Xu Zhang; Krishnamurthy P Gudehithlu; Jose A L Arruda; Ashok K Singh; Roberto F Machado; Victor R Gordeuk
Journal:  Transl Res       Date:  2018-02-02       Impact factor: 7.012

4.  Urinary markers of glomerular injury in diabetic nephropathy.

Authors:  Abraham Cohen-Bucay; Gautham Viswanathan
Journal:  Int J Nephrol       Date:  2012-05-08

Review 5.  Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Ligia Petrica; Romulus Timar; Silvia Velciov; Ioana Ionita; Adriana Kaycsa; Bogdan Timar
Journal:  J Diabetes Res       Date:  2016-06-16       Impact factor: 4.011

Review 6.  Diabetic nephropathy: What does the future hold?

Authors:  R M Montero; A Covic; L Gnudi; D Goldsmith
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.